Public Employees Retirement Association Of Colorado Seagen Inc. Transaction History

Public Employees Retirement Association Of Colorado

$23.2 Billion
Q1 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $14.2 Million - $16.1 Million	-74,377 Reduced 77.14%	22,039 $4.68 Million
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $14.2 Million - $16 Million	73,958 Added 329.32%	96,416 $6.56 Million
Q2 2023 Aug 09, 2023	BUY	$187.64 - $206.25 $5,441 - $5,981	29 Added 0.13%	22,458 $4.32 Million
Q1 2023 May 08, 2023	SELL	$127.59 - $203.08 $4,210 - $6,701	-33 Reduced 0.15%	22,429 $4.54 Million
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $5,281 - $6,262	-45 Reduced 0.2%	22,462 $2.89 Million

Q3 2022 Nov 15, 2022	SELL	$135.27 - $180.11 $1,217 - $1,620	-9 Reduced 0.04%	22,507 $3.08 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $8,487 - $13,987	-78 Reduced 0.35%	22,516 $3.98 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $19,735 - $26,045	-165 Reduced 0.72%	22,594 $3.26 Million
Q4 2021 Feb 11, 2022	SELL	$142.57 - $190.86 $13,401 - $17,940	-94 Reduced 0.41%	22,759 $3.52 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $4,700 - $5,604	-33 Reduced 0.14%	22,853 $3.88 Million
Q2 2021 Aug 13, 2021	BUY	$135.08 - $161.1 $46,872 - $55,901	347 Added 1.54%	22,886 $3.61 Million
Q1 2021 May 13, 2021	BUY	$137.51 - $190.8 $6,875 - $9,540	50 Added 0.22%	22,539 $3.13 Million
Q4 2020 Feb 11, 2021	BUY	$164.63 - $211.93 $3.7 Million - $4.77 Million	22,489 New	22,489 $3.94 Million

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.

Account